Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study

European Journal of Cancer

Volumn 51, Issue 15, 2015, Pages 2179-2190

  Crocetti, Emanuele ^a   Mallone, Sandra ^b   Robsahm, Trude Eid ^c   Gavin, Anna ^d   Agius, Domenic ^e   Ardanaz, Eva ^f,g   Lopez, Maria Dolores Chirlaque ^g,h   Innos, Kaire ⁱ   Minicozzi, Pamela ^j   Borgognoni, Lorenzo ^k   Pierannunzio, Daniela ^b   Eisemann, Nora ^l  

^a Descrittiva e Registri ISPO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e Malta National Cancer Registry   (Malta)

^f INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h Murcia Regional Health Authority   (Spain)

ⁱ NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^l UNIVERSITY OF LÜBECK   (Germany)

more..

Author keywords

Cancer survival; EUROCARE; European populations; Registries; Skin melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER SURVIVAL; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS MELANOMA; EUROPE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; PRIORITY JOURNAL; SKIN MANIFESTATION; SURVIVAL RATE; SURVIVAL TIME;

EID: 84942447088     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.07.039     Document Type: Article

References (44)

1. F. Erdmann, J. Lortet-Tieulent, J. Schüz, H. Zeeb, R. Greinert, E.W. Breitbart, and et al. International trends in the incidence of malignant melanoma 1953-2008 - Are recent generations at higher or lower risk? Int J Cancer 132 2013 385 400
2. Steliarova-Foucher E, O'Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer. Available from < http://eco.iarc.fr > (accessed on 4/September/2014).
3. M.R. Wehner, M.M. Chren, D. Nameth, A. Choudhry, M. Gaskins, K.T. Nead, and et al. International prevalence of indoor tanning: a systematic review and meta-analysis JAMA Dermatol 150 2014 390 400
4. C. Bosetti, P. Bertuccio, M. Malvezzi, F. Levi, L. Chatenoud, E. Negri, and C. La Vecchia Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980 Ann Oncol 24 2013 2657 2671
5. M. Sant, R. Capocaccia, M.P. Coleman, F. Berrino, G. Gatta, A. Micheli, and et al. Cancer survival increases in Europe, but international differences remain wide Eur J Cancer 37 2001 1659 1667
6. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - A population-based study Lancet Oncol 15 2014 23 34
7. C.M. Balch, S.J. Soong, M.B. Atkins, A.C. Buzaid, N. Cascinelli, D.G. Coit, and et al. An evidence-based staging system for cutaneous melanoma CA Cancer J Clin 54 2004 131 149
8. H. Cho, A.B. Mariotto, L.M. Schwartz, J. Luo, and S. Woloshin When do changes in cancer survival mean progress? The insight from population incidence and mortality J Natl Cancer Inst Monogr 49 2014 187 197
9. A.G. Fritz, C. Percy, A. Jack, and et al. International Classification of Diseases for Oncology (ICD-O) 3rd ed. 2000 World Health Organization Geneva
10. S. Rossi, P. Baili, M. Caldora, E. Carrani, P. Minicozzi, D. Pierannunzio, and et al. The EUROCARE-5 study on cancer survival in Europe: database, quality checks and methods of statistical analysis Eur J Cancer 51 2015 2104 2119
11. H. Brenner, O. Gefeller, and T. Hakulinen Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications Eur J Cancer 40 2004 326 335
12. H. Brenner, and T. Hakulinen Up-to-date long-term survival curves of patients with cancer by period analysis J Clin Oncol 20 2002 826 832
13. I. Corazziari, M. Quinn, and R. Capocaccia Standard cancer patient population for age standardising survival ratios Eur J Cancer 40 2004 2307 2316
14. F. Ederer, and H. Heise Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10 1959 End Results Evaluation Section, National Cancer Institute Bethesda, MD
15. K. Pearson Mathematical contributions to the theory of evolution - III. Regression, heredity, and panmixia Philos Trans R Soc Lond A 187 1896 253 318
16. SEER Stat Fact Sheets: Melanoma of the Skin. Available from: seer.cancer.govcite [cited 2015 Jul 3].
17. Australian Government Cancer Australia. Melanoma of the skin statistics [cited 2015 July 3] Available from: < http://www.canceraustralia.gov.au >.
18. M.P. Coleman, G. Gatta, A. Verdecchia, J. Estève, M. Sant, H. Storm, and et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century Annal Oncol 14 2003 v128 v149
19. E. de Vries, M. Boniol, J.F. Doré, J.W. Coebergh EUROCARE working group Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe Eur J Cancer 40 2004 1045 1052
20. M. Sant, C. Allemani, M. Santaquilani, A. Knijn, F. Marchesi, R. Capocaccia, and et al. EUROCARE- 4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary Eur J Cancer 45 2009 931 991
21. A.C. Geller, S.M. Swetter, S. Oliveria, S. Dusza, and A.C. Halpern Reducing mortality in individuals at high risk for advanced melanoma through education and screening J Am Acad Dermatol 65 2011 s87 s94
22. J.E. Mayer, S.M. Swetter, T. Fu, and A.C. Geller Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions: Part II. Screening, education, and future directions J Am Acad Dermatol 71 2014 611 e1-e611.e10
23. J.S. Schneider, D.H. Moore 2nd, and M.L. Mendelsohn Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996 J Am Acad Dermatol 58 2008 741 749
24. J.F. Aitken, J.M. Elwood, J.B. Lowe, D.W. Firman, K.P. Balanda, and I.T. Ring A randomised trial of population screening for melanoma J Med Screen 9 2002 33 37
25. S.M. Swetter, R.A. Pollitt, T.M. Johnson, D.R. Brooks, and A.C. Geller Behavioral determinants of successful early melanoma detection: role of self and physician skin examination Cancer 118 2012 3725 3734
26. A. Katalinic, A. Waldmann, M.A. Weinstock, A.C. Geller, N. Eisemann, R. Greinert, and et al. Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening Cancer 118 2012 5395 5402
27. J.F. Aitken, M. Elwood, P.D. Baade, P. Youl, and D. English Clinical whole-body skin examination reduces the incidence of thick melanomas Int J Cancer 126 2010 450 458
28. E.J. Glusac The melanoma 'epidemic': lessons from prostate cancer J Cutan Pathol 39 2012 17 20
29. C. Curiel-Lewandrowski, C.C. Kim, S.M. Swetter, S.C. Chen, A.C. Halpern, J.M. Kirkwood, and et al. Melanoma Prevention Working Group - Pigmented Skin Lesion Sub-Committee Survival is not the only valuable end point in melanoma screening J Invest Dermatol 132 2012 1332 1337
30. H.G. Welch, S. Woloshin, and L.M. Schwartz Skin biopsy rates and incidence of melanoma: population based ecological study BMJ 331 2005 481
31. H. Stefansson, L. Tryggvadottir, E.J. Olafsdottir, E. Mooney, J.H. Olafsson, B. Sigurgeirsson, and et al. Cutaneous melanoma in Iceland: changing Breslow's tumour thickness J Eur Acad Dermatol Venereol 29 2015 346 352
32. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605 613
33. H. Eriksson, J. Lyth, E. Månsson-Brahme, M. Frohm-Nilsson, C. Ingvar, C. Lindholm, and et al. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden Eur J Cancer 49 2013 2705 2716
34. A.J. Jiang, P.V. Rambhatla, and M.J. Eide Socioeconomic and lifestyle factors and melanoma: a systematic review Br J Dermatol 172 2015 885 915
35. A.J. Munro Comparative cancer survival in European countries Br Med Bull 110 2014 5 22
36. Paolo Baili, Francesca Di Salvo, Rafael Marcos-Gragera, Sabine Siesling, Sandra Mallone, Mariano Santaquilani, et al. Survival for all cancer patients diagnosed between 1999 and 2007 in Europe: results of EUROCARE-5, a population-based study. Eur J Cancer 2015;51:2120-9.
37. A.M. Eggermont, A. Spatz, and C. Robert Cutaneous melanoma Lancet 383 2014 816 827
38. M. Sant, T. Aareleid, F. Berrino, M. Bielska Lasota, P.M. Carli, J. Faivre, and et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary Ann Oncol 14 2003 v61 v118
39. A. Joosse, E. de Vries, R. Eckel, T. Nijsten, A.M. Eggermont, D. HÖlzel, and et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis J Invest Dermatol 131 2011 719 726
40. C. Bay, A.M. Kejs, H.H. Storm, and G. Engholm Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011 Cancer Epidemiol 39 2015 1 7
41. R. De Angelis, S. Francisci, P. Baili, F. Marchesi, P. Roazzi, A. Belot, and et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis Eur J Cancer 45 2009 909 930
42. G. Gatta, S. Mallone, J.M. van der Zwan, A. Trama, S. Siesling, R. Capocaccia, and et al. Cancer prevalence estimates in Europe at the beginning of 2000 Ann Oncol 24 2013 1660 1666
43. H.E. Karim-Kos, L.A.L.M. Kiemeney, M.W.J. Louwman, J.W.W. Coebergh, and E. de Vries Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation Int J Cancer 130 2012 2981 2989
44. IARC, WHO. European code against cancer - Fourth edition, 14 October 2014. Available at: < http://cancer-code-europe.iarc.fr >.